The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer

Introduction: Non-small cell lung cancer (NSCLC) is the second most common cancer globally. The mesenchymal-epithelial transition (MET) proto-oncogene can be targeted in NSCLC patients. Methods: We performed a literature search on PubMed in December 2019 for studies on MET inhibitors and NSCLC. Phas...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Med
Glavni autori: De Mello, Ramon Andrade, Neves, Nathália Moisés, Amaral, Giovanna Araújo, Lippo, Estela Gudin, Castelo-Branco, Pedro, Pozza, Daniel Humberto, Tajima, Carla Chizuru, Antoniou, Georgios
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7356188/
https://ncbi.nlm.nih.gov/pubmed/32575417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061918
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items